[HTML][HTML] Clinical findings in 111 cases of influenza A (H7N9) virus infection
…, ZC Jin, Q Chen, C Tang, ZY Zhang… - … England Journal of …, 2013 - Mass Medical Soc
Background During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged
and spread among humans in China. Data were lacking on the clinical characteristics of …
and spread among humans in China. Data were lacking on the clinical characteristics of …
Effect of water absorption on the mechanical properties of hemp fibre reinforced unsaturated polyester composites
HN Dhakal, ZY Zhang, MOW Richardson - Composites science and …, 2007 - Elsevier
Hemp fibre reinforced unsaturated polyester composites (HFRUPE) were subjected to water
immersion tests in order to study the effects of water absorption on the mechanical …
immersion tests in order to study the effects of water absorption on the mechanical …
[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …
Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …
blood pressure ranges in people with or without pre-existing cardiovascular disease …
Human P450 metabolism of warfarin
LS Kaminsky, ZY Zhang - Pharmacology & therapeutics, 1997 - Elsevier
The anticoagulant drug warfarin occurs as a pair of enantiomers that are differentially
metabolized by human cytochromes P450 (CYP). R-warfarin is metabolized primarily by CYP1A2 …
metabolized by human cytochromes P450 (CYP). R-warfarin is metabolized primarily by CYP1A2 …
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
S Zhang, ZY Zhang - Drug discovery today, 2007 - Elsevier
Protein tyrosine phosphatase 1B (PTP1B) is an effective target for the treatment of both type
2 diabetes and obesity; however, targeting PTP1B for drug discovery is challenging because …
2 diabetes and obesity; however, targeting PTP1B for drug discovery is challenging because …
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
…, BI Ghanayem, DA Bell, ZY Zhang… - Pharmacogenetics …, 1996 - journals.lww.com
Tolbutamide undergoes hydroxylation in humans via a cytochrome P450-mediated pathway.
The primary P450 isozyme responsible for this metabolism is thought to be CYP2C9. …
The primary P450 isozyme responsible for this metabolism is thought to be CYP2C9. …
[PDF][PDF] Structural and functional analysis of the costimulatory receptor programmed death-1
… Z. Dauter for assistance with data collection, and Dr. M. … Z. Dauter for assistance with data
collection, and Dr. Brenowitz … XG and Z.-YZ are supported in part by the G. Harold and Leila Y…
collection, and Dr. Brenowitz … XG and Z.-YZ are supported in part by the G. Harold and Leila Y…
Nickel–cobalt diselenide 3D mesoporous nanosheet networks supported on Ni foam: an all‐pH highly efficient integrated electrocatalyst for hydrogen evolution
Novel 3D Ni 1− x Co x Se 2 mesoporous nanosheet networks with tunable stoichiometry are
successfully synthesized on Ni foam (Ni 1− x Co x Se 2 MNSN/NF with x ranging from 0 to …
successfully synthesized on Ni foam (Ni 1− x Co x Se 2 MNSN/NF with x ranging from 0 to …
Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development
ZY Zhang - Annual review of pharmacology and toxicology, 2002 - annualreviews.org
… In addition, some difluorophosphonate PTP1B inhibitors display insulin mimetic activity in
vivo (ZY. Zhang, unpublished results). On the other hand, since the PTP active site is designed …
vivo (ZY. Zhang, unpublished results). On the other hand, since the PTP active site is designed …
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo …
…, X Ai, ZY Zhang, YG Ji, FJ Luo, XQ Chen, Y Zhang… - The Lancet, 2013 - thelancet.com
Background A vaccine for enterovirus 71 (EV71) is needed to address the high burden of
disease associated with infection. We assessed the efficacy, safety, immunogenicity, antibody …
disease associated with infection. We assessed the efficacy, safety, immunogenicity, antibody …